Adjuvant chemotherapy following chemoradiotherapy as primary treatment for locally advanced cervical cancer versus chemoradiotherapy alone (OUTBACK): an international, open-label, randomised, phase 3 trial.

Saved in:
Bibliographic Details
Title: Adjuvant chemotherapy following chemoradiotherapy as primary treatment for locally advanced cervical cancer versus chemoradiotherapy alone (OUTBACK): an international, open-label, randomised, phase 3 trial.
Authors: Mileshkin LR; Department of Medical Oncology, Peter MacCallum Cancer Centre and University of Melbourne, Melbourne, VIC, Australia. Electronic address: linda.mileshkin@petermac.org., Moore KN; Stephenson Cancer Center at the University of Oklahoma, Oklahoma City, OK, USA., Barnes EH; National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Sydney, NSW, Australia., Gebski V; National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Sydney, NSW, Australia., Narayan K; Department of Radiation Oncology, Peter MacCallum Cancer Centre and University of Melbourne, Melbourne, VIC, Australia., King MT; School of Psychology, University of Sydney, Sydney, NSW, Australia., Bradshaw N; National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Sydney, NSW, Australia., Lee YC; National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Sydney, NSW, Australia., Diamante K; National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Sydney, NSW, Australia., Fyles AW; National Cancer Institute of Canada Clinical Trial Group, Radiation Medicine Program, Princess Margaret Cancer Centre, Toronto, ON, Canada., Small W Jr; Department of Radiation Oncology, Stritch School of Medicine, Cardinal Bernadin Cancer Center, Loyola University Chicago, Maywood, IL, USA., Gaffney DK; Department of Radiation Oncology, Huntsman Cancer Institute at the University of Utah, Salt Lake City, UT, USA., Khaw P; Department of Radiation Oncology, Peter MacCallum Cancer Centre and University of Melbourne, Melbourne, VIC, Australia., Brooks S; Department of Medical Oncology, Auckland City Hospital, Auckland, New Zealand., Thompson JS; Stephenson Cancer Center at the University of Oklahoma, Oklahoma City, OK, USA., Huh WK; University of Alabama at Birmingham, Birmingham, AL, USA., Mathews CA; Program in Women's Oncology, Department of Obstetrics and Gynecology, Women and Infants Hospital, Brown University, Providence, RI, USA., Buck M; Department of Medical Oncology, Sir Charles Gairdner Hospital, Perth, WA, Australia., Suder A; Department of Medical Oncology, Royal Brisbane and Women's Hospital, Brisbane, QLD, Australia., Lad TE; Division of Hematology-Oncology, Cook County Hospital, Chicago, IL, USA., Barani IJ; Department of Radiation Oncology, St Joseph's Hospital and Medical Centre, Phoenix, AZ, USA., Holschneider CH; Division of Gynecologic Oncology, University of California, Los Angeles, Los Angeles, CA, USA., Van Dyk S; Department of Radiation Oncology, Peter MacCallum Cancer Centre and University of Melbourne, Melbourne, VIC, Australia., Quinn M; Oncology Unit, Royal Women's Hospital and University of Melbourne, Melbourne, VIC, Australia., Rischin D; Department of Medical Oncology, Peter MacCallum Cancer Centre and University of Melbourne, Melbourne, VIC, Australia., Monk BJ; Division of Gynecologic Oncology, HonorHealth Research Institute, University of Arizona, Creighton University, Phoenix, AZ, USA., Stockler MR; National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Sydney, NSW, Australia.
Source: The Lancet. Oncology [Lancet Oncol] 2023 May; Vol. 24 (5), pp. 468-482. Date of Electronic Publication: 2023 Apr 17.
Publication Type: Randomized Controlled Trial; Multicenter Study; Clinical Trial, Phase III; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Lancet Pub. Group Country of Publication: England NLM ID: 100957246 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1474-5488 (Electronic) Linking ISSN: 14702045 NLM ISO Abbreviation: Lancet Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1474-5488
DOI:10.1016/S1470-2045(23)00147-X